Rahul Keswani

Company: Arbor Biotechnologies

Job title: Associate Director - Non-Viral Gene Therapy

Seminars:

Advancing Gene Editing Applications for LNPs 2:30 pm

Looking into the development and potential of LNPs, gene editing is a clear area of interest. Gene editing is attractive beneficial therapeutic option for treating various diseases. Some barriers arise in the delivery of gene editing components. LNPs can offer safe, efficacious promise for the future of gene editing. We will discuss considerations when using…Read more

day: Focus Day Track A PM 3